Table 1.
Lymph node metastasis | Distant metastasis | |
---|---|---|
Number of patients | 14 | 9 |
with 2 samples | 14 | 7 |
with 3 samples | 0 | 2 |
Age, mean, range (years) | 54, 25-79 | 53, 36-68 |
Site of metastasis | ||
Axilla | 14 | |
Abdomen | 3 | |
Lung | 2 | |
Skeleton | 2 | |
Skin | 2 | |
Ipsilateral breast | 1 | |
Contralateral axilla | 1 | |
Tumour sizea, mean range (mm) | 35, 10-110 | 19, 13-28 |
Missing | 0 | 2 |
ERa | ||
Positive | 8 | 6 |
Negative | 6 | 3 |
ERb | ||
Positive | 7 | 4 |
Negative | 5 | 4c |
Missing | 2 | 3 |
Adjuvant treatmentd | ||
Radiotherapy | 78% | 22% |
Endocrine therapy | 64% | 22% |
Chemotherapy | 43% | 11% |
Neoadjuvant treatmente | ||
Chemotherapy | 14% | 0% |
aOf the primary tumour.
bOf the metastasis.
cOne patient had an ER+ primary tumour and an ER- distant metastasis.
dAfter primary surgery.
eBefore primary surgery.